overt nephropathy

Related by string. * Overt : overt hepatic encephalopathy HE . overt hepatic encephalopathy . overt betrayal . overt sexism . overt hostility . overt sexuality . overt politicking / Nephropathy : Contrast Induced Nephropathy CIN . IgA nephropathy . chronic allograft nephropathy . diabetic nephropathy . hypertension diabetic nephropathy . membranous nephropathy . nephropathy * *

Related by context. All words. (Click for frequent words.) 73 SGPT 72 diabetes mellitus DM 72 macroalbuminuria 72 hyperphenylalaninemia HPA due 72 relapsed MM 71 glycated hemoglobin levels 71 hepatorenal syndrome 71 colorectal adenoma 71 proliferative retinopathy 71 diabetic kidney 70 Hypotension 70 serum phosphate 70 AGILECT R 70 torsade de pointes 70 mild renal insufficiency 70 diabetes mellitus T2DM 69 PLX STROKE targeting 69 hematopoietic cancers 69 systemic corticosteroid 69 secondary hyperparathyroidism 69 alanine aminotransferase ALT 69 corticosteroid dose 69 CrCl 69 hypercalciuria 69 glycosylated hemoglobin HbA1c 69 metastatic GIST 69 oral antidiabetic medication 69 hypophosphatemia 68 Infusion Reactions Severe 68 non splenectomized 68 proliferative diabetic retinopathy 68 metastatic malignant 68 lipid lowering agents 68 ACTEMRA TM 68 NIASPAN 68 NATRECOR R 68 insulin glulisine 68 pulmonary exacerbations 68 chronic thromboembolic pulmonary 68 Naive Patients 68 atherogenic dyslipidemia 68 systolic hypertension 68 genotypic resistance 68 cytopenias 68 Microalbuminuria 68 hypocalcemia 68 CTAP# Capsules 68 NNT = 68 hour bronchodilation 68 antidiabetic medications 68 serum phosphorous 68 kidney urologic 68 HBeAg negative 68 postoperative AF 68 deep venous thromboses 68 certolizumab 68 clinically meaningful reductions 68 alanine aminotransferase 68 primary aldosteronism 68 β blockers 68 ATACAND 68 glomerular filtration 67 Tasigna prolongs 67 elevated serum creatinine 67 CYT# potent vascular disrupting 67 renal dysfunction 67 renal insufficiency 67 FluCAM arm 67 elevated ALT 67 SHPT 67 AVAPRO 67 confidence interval #.#-#.# 67 KRAS mutations occur 67 AGHD 67 nonalcoholic steatohepatitis 67 maximal doses 67 recurrent glioblastoma multiforme 67 nicardipine 67 primary hyperparathyroidism 67 anagrelide 67 improves glycemic 67 HER2 overexpression 67 thromboembolic disease 67 extrapyramidal symptoms 67 leucopenia 67 nonalcoholic steatohepatitis NASH 67 systemic hypotension 67 reduce serum phosphate 67 progressive dyspnea 67 aspirin clopidogrel 67 PAOD 67 Fasting blood glucose 67 postoperative pulmonary 67 onset diabetes mellitus 67 metformin sulfonylurea 67 microalbuminuria 67 diabetic gastroparesis 67 HeFH 67 Erythropoietic therapies may 67 myocardial infarction ventricular fibrillation 67 COPD exacerbation 67 moderate renal impairment 67 aminotransferases 67 somatostatin analog 67 BENICAR HCT 67 lispro 67 ionotropic 67 severe renal impairment 67 macrovascular disease 66 primary hypercholesterolemia 66 elevated IOP 66 octreotide LAR 66 dopaminergic therapy 66 adjunctive placebo 66 parasitemia 66 hypercholesterolaemia 66 vitamin B# folic acid 66 endometrial hyperplasia 66 complement inhibitor eculizumab 66 vWD 66 smoldering myeloma 66 induce orthostatic hypotension 66 basal cell nevus syndrome 66 posttransplant 66 retinal vein occlusion induced 66 bronchopulmonary dysplasia BPD 66 BYSTOLIC 66 hypertension diabetes mellitus 66 psoriatic arthritis PsA 66 Chronic pancreatitis 66 primidone 66 acromegalic patients 66 pericardial effusion 66 inflammatory biomarkers 66 leukemia AML 66 Impaired glucose tolerance 66 paricalcitol 66 clevidipine 66 NMIBC 66 smoldering multiple myeloma 66 Myelodysplastic Syndrome MDS 66 hemoglobin A1c HbA1c 66 colorectal liver metastases 66 Mg Usa 66 salmeterol fluticasone 66 VAPRISOL 66 paroxysmal AF 66 alpha1 antitrypsin deficiency 66 bronchial hyperresponsiveness 66 serum urate levels 66 mitoxantrone plus 66 thetreatment 66 aspartate aminotransferase AST 66 apolipoprotein E4 66 urine albumin 66 anticholinergic agents 66 inotropic 66 rheumatoid arthritis osteoarthritis ankylosing 66 xanthine oxidase inhibitor 66 nucleotide analog 66 fibrinolysis 66 either acutely decompensated 66 recurrent VTE 66 BENICAR 66 metformin sulfonylureas 66 Ribavirin causes 66 severe exacerbations 66 APTIVUS r 66 PRADAXA #mg 66 elevated uric acid 66 poor metabolizers 66 INVEGA ® 66 hematologic toxicity 66 metastatic neuroendocrine tumors 66 erosive gastritis 66 biologic DMARD 66 myelodysplastic myeloproliferative diseases 66 serum aminotransferase levels 66 T2DM 66 interferon ribavirin 66 convulsive disorders 66 recurrent venous thromboembolism 66 neovascularisation 66 hypokalemia 66 BARACLUDE ® 66 irbesartan 66 receiving VELCADE 66 T1DM 66 cardiac repolarization 66 EDARBI 66 basal bolus regimen 66 hepatic fibrosis 66 mixed hyperlipidemia 66 oral hypoglycemic agents 66 HbA 1c levels 66 intravascular hemolysis 66 liver histology 66 receiving XGEVA 66 ß blockers 66 refractory gout 66 Proteinuria 66 hypervolemic hyponatremia 66 hematological parameters 66 E selectin 66 dysglycemia 65 QTcF 65 aspartate aminotransferase 65 IFN beta 65 poststroke 65 metabolic alkalosis 65 neovascular 65 transaminase elevations 65 AST ALT 65 TOVIAZ 65 interferon beta therapy 65 pulmonary hypertension PH 65 intracranial atherosclerosis 65 acetonide FA 65 left ventricular dysfunction 65 invasive candidiasis 65 fibrin deposition 65 intravenous RSD# 65 thrombocytopenic 65 TMP SMX 65 topical calcineurin inhibitors 65 6R BH4 65 left ventricular systolic 65 Heavy menstrual bleeding 65 cervical intraepithelial neoplasia 65 QTc prolongation 65 impaired glucose metabolism 65 Lixivaptan 65 Aortic stenosis 65 lipid lowering therapies 65 brand ciclesonide HFA 65 serum phosphate levels 65 dalteparin 65 dihydrochloride 65 beta blockers ACE inhibitors 65 mcg BID 65 mild renal impairment 65 thromboembolic complications 65 ADPKD 65 hyperparathyroidism 65 CTAP# 65 PSA nadir 65 ovarian carcinoma 65 candidemia 65 containing abacavir 65 bezafibrate 65 venlafaxine Effexor 65 cerebrovascular events 65 nondiabetic patients 65 Haptoglobin 65 benazepril 65 cinacalcet 65 sulfonylurea metformin 65 AA Amyloidosis 65 antiarrhythmic drug 65 corticosteroid therapy 65 PEGINTRON TM 65 EXJADE 65 elevated LDL cholesterol 65 BEXXAR Therapeutic Regimen 65 haematologic 65 IOP lowering 65 splenectomized 65 CIMZIA TM certolizumab pegol 65 flutamide 65 Hypertriglyceridemia 65 ACE Inhibitors 65 mL/min/#.# m 2 65 lomitapide 65 cyclophosphamide methotrexate 65 CIMZIA TM 65 schizophrenia CIAS 65 achieved ACR# 65 pouchitis 65 triiodothyronine 65 unstable angina pectoris 65 glycosylated hemoglobin levels 65 hypokalemia hypomagnesemia 65 ancrod 65 nephropathy 65 blood phenylalanine Phe 65 baseline serum creatinine 65 OSAHS 65 Lymphocytic 65 Mitomycin C 65 valsartan amlodipine 65 hepatitis C genotype 65 p = NS 65 thoracoscopic lobectomy 65 selective modulator 65 MCyR 65 antidiabetic medication 65 Teriflunomide 65 post thrombotic syndrome 65 serum potassium 65 atazanavir ritonavir 65 abacavir Ziagen 65 induce remission 65 colorectal carcinoma 65 hepatic steatosis 65 peripheral arterial occlusive disease 65 prostate TURP 65 non cirrhotic portal 65 Fasting glucose 65 Clinically significant 65 macrovascular events 65 weekly subcutaneous injections 65 papillary renal cell carcinoma 65 histologic subtype 65 DETROL LA 65 refractory AML 65 synthetic retinoid 65 Fluid retention 65 sargramostim 65 GH deficiency 65 % CI #.#-#.# [007] 65 proliferator activated receptor 65 cystoid macular edema 65 Diabetic neuropathy 65 generalized seizures 65 anemia hemoglobin 65 idiopathic Parkinson disease 65 Hyperphosphatemia 65 ARB telmisartan 65 direct thrombin inhibitors 65 glycated hemoglobin HbA1c 65 ritonavir boosted protease inhibitor 65 diabetic retinopathy DR 65 hypomagnesemia 65 hemoglobin A1c levels 65 Diabetic nephropathy 65 hepatotoxicity 65 polycythemia vera essential thrombocythemia 65 oral antidiabetes 65 ACTOplus met XR 65 achieved CCyR 65 vaso occlusive crisis 65 advanced adenoma 65 isolated systolic hypertension 65 variant angina 65 transcranial Doppler ultrasound 65 pioglitazone HCl 65 adjunctive ABILIFY 65 cis retinoic acid 65 anterior uveitis 65 neurologic progression 65 Vaprisol 65 conventional DMARDs 65 tardive dyskinesia TD 65 reteplase 65 hyperbilirubinemia 65 Mg Uk 65 efalizumab 65 intact parathyroid hormone 65 4mg/kg 65 arterial thromboembolic events 65 metformin hydrochloride 65 ULORIC 65 SGOT 65 grade cervical intraepithelial 64 azilsartan medoxomil 64 urate lowering 64 gastrointestinal perforation 64 juvenile idiopathic arthritis JIA 64 electrolyte abnormalities 64 lanthanum carbonate 64 % CI #.#-#.# [003] 64 unresectable tumors 64 idarubicin 64 TNF antagonist 64 antiarrhythmic 64 inhaled budesonide 64 FRAGMIN 64 TEAEs 64 colesevelam HCl 64 N telopeptide 64 lactate dehydrogenase 64 hyperlipidaemia 64 hyperprolactinemia 64 heparin induced thrombocytopenia 64 pharmacologic stress 64 idiopathic thrombocytopenic purpura 64 tacrolimus ointment 64 NNRTI resistance 64 GAMMAGARD 64 hypocalcaemia 64 Interferon beta 1b 64 delta gamma agonist 64 cerebral vasospasm 64 elevated triglyceride levels 64 peritumoral brain edema 64 Amgen Neulasta R 64 adenomatous 64 potassium sparing diuretics 64 tamoxifen Nolvadex ® 64 antihypertensive therapy 64 neurodevelopmental impairment 64 prednisone prednisolone 64 protein excretion 64 thyrotoxicosis 64 venlafaxine XR 64 thromboxane A2 64 tolterodine ER 64 unresectable HCC 64 VIIBRYD 64 thalidomide Thalomid 64 pyridostigmine 64 hepatic cirrhosis 64 ANCA associated 64 fasting plasma glucose FPG 64 FOSRENOL ® 64 HMG CoA reductase inhibitors 64 x ULN 64 MYLOTARG 64 thrombocytopenic patients 64 diabetes dyslipidemia 64 coronary artery atherosclerosis 64 renal scarring 64 hyperlipemia 64 aldosterone antagonist 64 candesartan cilexetil 64 generalized tonic clonic seizures 64 CIMZIA ™ 64 clomipramine 64 pentoxifylline 64 abacavir lamivudine 64 hyperglycemia 64 urolithiasis 64 NATRECOR ® 64 MIRAPEX ER 64 aplindore 64 Febrile neutropenia 64 hypervascular tumors 64 topically administered 64 Vidaza ® 64 YONDELIS 64 Inhaled nitric oxide 64 amoxicillin clavulanate 64 Venous thromboembolism 64 SUSTENNA TM 64 acarbose 64 ZOLINZA 64 toenail onychomycosis 64 nitrofurantoin 64 comorbid depression 64 ALT flares 64 HIV HCV coinfected 64 Alzheimer Disease AD 64 FUSILEV enhances 64 hyperglycaemia 64 non valvular atrial 64 coagulation disorders 64 serum triglyceride levels 64 gastric carcinoma 64 plasma kallikrein inhibitor 64 timepoints 64 voriconazole 64 postoperative delirium 64 metformin sulphonylurea 64 systemic corticosteroids 64 left ventricular diastolic 64 microalbumin 64 LymphoStat B belimumab 64 intermittent claudication 64 hepatic encephalopathy HE 64 abnormal lipid 64 antiangiogenic therapy 64 atopic asthma 64 bronchoalveolar lavage 64 ribavirin RBV 64 proteinuria 64 moderate hepatic impairment 64 thiazide diuretic 64 ritonavir boosted 64 retinal vein occlusion 64 artery stenosis 64 terlipressin 64 coagulopathy 64 SCr 64 NYHA Class II 64 ALT elevations 64 chronic eosinophilic leukemia 64 STRIDE PD 64 choroidal neovascularization 64 recurrent acute pancreatitis 64 Abrupt discontinuation 64 TNF Tumor Necrosis Factor 64 silent ischemia 64 Alzheimer disease vascular dementia 64 morphometric vertebral fractures 64 flecainide 64 Avandia Actos 64 LV dysfunction 64 coronary stenosis 64 serum PTH 64 severe neutropenia 64 de novo kidney transplant 64 glomerular filtration rate 64 CYP#A# CYP#D# 64 induced anemia 64 NAGS deficiency 64 de novo AML 64 hypereosinophilic syndrome 64 atypical hemolytic uremic syndrome 64 myeloperoxidase 64 isoenzyme 64 Natalizumab 64 paroxysmal supraventricular tachycardia 64 serum sodium levels 64 trandolapril 64 Polyneuropathy 64 milrinone 64 moderately emetogenic 64 progressive neurodegenerative disorder 64 dopamine partial agonist 64 R Saizen R 64 CC genotype 64 lactate dehydrogenase LDH 64 Kinoid 64 rFSH 64 MULTAQ 64 chorioamnionitis 64 GnRH agonist 64 claudication 64 baseline HbA1c 64 bisoprolol 64 corrected QT interval 64 Hb A1C 64 NPH insulin 64 serum lipid levels 64 secondary amenorrhea 64 #mg/day [002] 64 rhIGF-I/rhIGFBP-3 64 subclinical hypothyroidism 64 forodesine 64 systemic fungal infections 64 HER2 expression 64 Cloretazine 64 lysosomal enzyme iduronate 64 ara C 64 hyperammonemia 64 antiemetics 64 complete cytogenetic response 64 receptor tyrosine kinase inhibitor 64 PSADT 64 Perforomist ™ Inhalation Solution 64 pulmonary dysfunction 64 chronic GVHD 64 biochemical relapse 64 K ras mutations 64 secondary hyperparathyroidism SHPT 64 oral hypoglycemic agent 64 visilizumab 64 NovoLog ® Mix 64 receiving ISENTRESS 64 recurrent atrial fibrillation 64 ruboxistaurin 64 elevated fasting glucose 64 isoproterenol 64 8mg/kg 64 femoral neck fracture 64 antithyroid 64 symptomatic paroxysmal AF 64 serum urate 64 hemodialysis patients 64 caspofungin 64 intravenous diuretics 64 ribavirin USP 64 mcg QD 64 intravesical therapy 64 PREZISTA r arm 64 autoantibody positive 64 anticoagulant warfarin 64 Severe hypoglycemia 64 GSTP1 64 pharmacologically active isomer 64 binding protein IGFBP 64 recurrent glioblastoma 64 biphasic insulin aspart 64 echocardiographic parameters 64 C1 INH deficiency 64 diabetic microvascular complications 64 sorafenib tablets 64 CI -#.# 64 dyslipidaemia 64 chronic idiopathic thrombocytopenic purpura 64 Vidaza azacitidine 64 tipranavir r 64 transaminase levels 64 LAB CGRP 64 Primary IGFD 64 geographic atrophy 64 relapsed refractory AML 64 pravastatin Pravachol 64 euvolemic 64 Gestational diabetes 64 PEGylated anti 64 hepatic enzymes 64 idraparinux 64 serum cortisol 64 detrusor overactivity 64 PPAR gamma agonist 64 serum leptin 64 Lung transplantation 64 metabolic disturbances 64 radiotherapy RT 64 inhibitor RG# 64 prescribed proton pump 64 symptomatic VTE 64 coagulation abnormalities 64 intima media thickness 64 chronic immune thrombocytopenic 64 COPEGUS therapy 64 quetiapine Seroquel 64 perioperatively 64 lumiliximab 63 cough dyspnea 63 ximelagatran 63 HBeAg negative patients 63 valvular disease 63 verteporfin 63 MADRS score 63 thromboembolic 63 variceal bleeding 63 indinavir 63 allogeneic HSCT 63 clodronate 63 teriflunomide 63 novel VDA molecule 63 dissolving blood clots 63 inflammatory acne 63 fluticasone salmeterol 63 Thrombocytopenia 63 lymphopenia 63 apolipoprotein B 63 metaglidasen 63 plus prednisone prednisolone 63 CTEPH 63 D aspartate NMDA receptor 63 PPAR agonist 63 hepatic insufficiency 63 contrast induced nephropathy 63 carotid atherosclerosis 63 somatostatin analogs 63 pancreatic insufficiency 63 Adenomas 63 Hepatocellular Carcinoma HCC 63 Intravenous immunoglobulin 63 ABCB1 63 subarachnoid hemorrhage SAH 63 CYP#A# substrate 63 severe hypoglycaemia 63 dasatinib Sprycel 63 catheter occlusion 63 familial hypercholesterolemia 63 myopathy rhabdomyolysis 63 intravenous cyclophosphamide 63 PREZISTA r 63 basal bolus therapy 63 oxaliplatin Eloxatin 63 relapsing remitting MS RRMS 63 G6PD deficiency 63 titrated glipizide 63 serum homocysteine 63 Xyfid TM 63 TPMT 63 leukotriene receptor antagonist 63 dasatinib Sprycel ® 63 Non Alcoholic Steatohepatitis 63 IDDM 63 metabolic acidosis 63 orally administered synthetic retinoid 63 preserved ejection fraction 63 affective psychosis 63 metformin Glucophage 63 myeloproliferative diseases 63 PARGLUVA 63 Folfox 63 nutlin 3a 63 corticosteroid induced 63 pamidronate 63 conjunctival hyperemia 63 inhaled iloprost 63 Patients Receiving 63 systolic dysfunction 63 alemtuzumab treated 63 β blocker 63 albumin excretion 63 hepatocellular carcinomas 63 node metastases 63 hypercoagulable 63 autonomic dysfunction 63 Pegloticase 63 ventricular remodeling 63 idiopathic myelofibrosis 63 serum calcium levels 63 vWF 63 Hp2 2 63 Ischemic 63 receiving VICTRELIS 63 intracranial hemorrhage ICH 63 postoperative complication 63 advanced adenomas 63 chronic periodontitis 63 Juvenile Idiopathic Arthritis 63 linoleic acid LA 63 ALT elevation 63 INCB# [003] 63 cardiovascular calcification 63 systemic lupus erythematosus SLE 63 fasting triglyceride levels 63 euthymic patients 63 sitaxsentan 63 EDSS scores 63 Known hypersensitivity 63 oxypurinol 63 nonhematologic adverse reactions 63 Aggrastat ® tirofiban hydrochloride 63 vitreous floaters 63 anticoagulants blood thinners 63 mucosal inflammation 63 atrophic gastritis 63 cell adhesion molecule 63 Zollinger Ellison Syndrome 63 reflux disease GERD 63 leukotriene B4 63 pharmacologic therapies 63 rFVIIa 63 bacterial prostatitis 63 Plaquenil 63 gestational hypertension 63 leukocyte count 63 plasma uric acid 63 postoperative morbidity 63 bullous 63 MGd 63 acute coronary syndromes ACS 63 CHOP chemotherapy 63 antiepileptic medications 63 PNH patients 63 embolic stroke 63 postprandial glycemia 63 Lantus ® 63 leiomyomas 63 oral FTY# 63 acute mania 63 hemorrhagic cystitis 63 choroidal neovascularization CNV 63 decompensated cirrhosis 63 peptide BNP 63 â ‰ ¥ 63 pmol L 63 hyperplasia BPH 63 tachyarrhythmias 63 albumin excretion rate 63 pyrazinamide 63 juvenile idiopathic arthritis 63 electrical cardioversion 63 nonfatal myocardial infarction MI 63 gefitinib Iressa 63 PASI scores 63 edifoligide 63 diarrhea predominant irritable 63 salmeterol HFA MDI 63 alpha1 antitrypsin AAT deficiency 63 venous thromboembolic disease 63 acute GvHD 63 oxcarbazepine 63 Ishak fibrosis score 63 plasma renin activity 63 PsA 63 nadroparin 63 constipation OIC 63 octreotide acetate 63 micafungin 63 acne vulgaris 63 obstructive CAD 63 systemic antifungal 63 Lantus insulin 63 urethral stricture 63 plus methotrexate 63 Helicobacter pylori eradication 63 brimonidine 63 QD dosing 63 piperacillin tazobactam 63 refractory NSCLC 63 subcutaneous immunoglobulin 63 pheochromocytoma 63 thromboembolic events 63 venous stasis ulcers 63 lopinavir r arm 63 AEGR 63 stavudine d4T 63 thrombotic complications 63 prospective multicenter study 63 thyrotropin 63 urate lowering therapy 63 intra abdominal abscess 63 chronic renal disease 63 antiphospholipid syndrome 63 erlotinib Tarceva ® 63 metastatic gastric 63 CRVO 63 Hyperlipidemia 63 oxycodone CR 63 arterial calcification 63 hyperoxaluria 63 H. pylori eradication 63 adalimumab Humira 63 symptomatic intracranial 63 herpes zoster shingles 63 serum triglycerides 63 induced macular edema 63 hepatic function 63 levodopa carbidopa 63 delivers fluocinolone acetonide FA 63 ursodeoxycholic acid 63 glulisine 63 histological subtype 63 trimethoprim sulfamethoxazole 63 SPIRIVA ® 63 amphotericin B 63 Relapsing remitting MS 63 CIMZIA R 63 gastrointestinal mucositis 63 oral antidiabetic drugs 63 polycythemia vera PV 63 aldosterone antagonists 63 intravenous IV infusion 63 beta 1a 63 Sudhir Agrawal D.Phil 63 Valcyte tablets 63 Postoperative complications 63 SIADH 63 targeted radiotherapeutic 63 corifollitropin alfa 63 chemoradiation therapy 63 hyperphosphataemia 63 oral hypoglycemic 63 metaplasia 63 Serum creatinine 63 Glucophage metformin 63 tapentadol ER 63 formoterol fumarate 63 unfavorable cytogenetics 63 Bronchopulmonary Dysplasia 63 decompensated heart failure 63 Urocortin 2 63 ® lenalidomide 63 lumbar spinal stenosis LSS 63 dysfunction LVSD 63 INTEGRILIN R 63 grade cervical dysplasia 63 neutropenic sepsis 63 airway hyperresponsiveness 63 severe mitral regurgitation 63 perfusion MRI 63 sitosterol 63 rhIGFBP 3 63 lipid parameters 63 uM 63 EFFEXOR XR 63 Thiazolidinediones 63 TAXUS p value 63 overactive bladder syndrome 63 coronary calcification 63 Acute myeloid leukemia 63 opioid naive 63 #mg doses [002] 63 exudative AMD 63 pharmacologic treatments 63 cystic fibrosis chronic pancreatitis 63 Insulin PH# 63 miconazole Lauriad ® 63 concomitant medications 63 chronic myeloid 63 VELCADE melphalan 63 lipid elevations 63 Secondary Hyperparathyroidism 63 pegaptanib 63 bladder carcinoma 63 myocardial ischaemia 63 refractory cutaneous T 63 stratifying patients 63 taxane resistant 63 Nebulized 63 busulfan 63 myelofibrosis polycythemia vera 63 thromboembolism 63 infliximab monotherapy 63 #.#mmol L [002] 63 daunorubicin 63 subependymal giant cell 63 NYHA functional class 63 neovascular glaucoma 63 CYP #A# 63 #mg/day [001] 63 lichen planus 63 vulvovaginal atrophy 63 Glioblastoma Multiforme GBM 63 IFN alfa 63 Zorbtive TM 63 DITPA 63 cytomegalovirus infection 63 calculated creatinine clearance 63 hyperhomocysteinemia 63 preintervention 63 hemorrhagic complications 63 ertapenem 63 antithrombotic therapy 63 placebo PBO 63 NIDDM 63 macular edema secondary 63 overactive bladder symptoms 63 asymptomatic hyperuricemia 63 patientswith 63 μmol L 63 Insulin detemir 63 R entecavir 63 Aflibercept 63 riociguat 63 NSAID associated 63 #mg BID [001] 63 bardoxolone methyl 63 reinfarction 63 endothelial activation 63 See WARNINGS 63 COREG 63 mmHg diastolic 63 dose cohort 63 DAS# CRP 63 Combination therapy 63 FOLFOX4 63 Cystatin C 63 folinic acid 63 aflibercept VEGF Trap 63 hypercholesterolemia 63 #.#/#.# mmHg [001] 63 ophthalmologic disorders 63 IGFBP 63 gemcitabine cisplatin 63 prostaglandin analogues 63 oral antidiabetic agents 63 plasma pharmacokinetics 63 Apidra ® 63 Acute Renal Failure 63 atrial arrhythmias 63 elevated transaminases 63 monoclonal gammopathy 63 androgen ablation 62 nortriptyline Pamelor 62 urinary albumin 62 % CI #.#-#.# [001] 62 gamma secretase inhibitor 62 macrovascular complications 62 noncardiac 62 serum creatinine levels 62 zonisamide SR 62 TTR amyloidosis 62 RAS mutations 62 bioprosthetic valve 62 % AST SGOT 62 salmeterol inhalation powder 62 antiretroviral naive 62 tumor histology 62 AZT zidovudine Retrovir 62 generalized edema 62 gastric adenocarcinoma 62 mg BID dose 62 keloid scarring 62 Testosterone deficiency 62 Tasimelteon 62 atherosclerotic disease 62 Orally administered 62 serum parathyroid hormone 62 myocardial infarctions MIs 62 2 methoxyestradiol 62 Systemic lupus erythematosus SLE 62 postmenopausal osteoporotic women 62 Non Alcoholic Fatty 62 Acute Coronary Syndromes ACS 62 postintervention 62 albuminuria 62 ropivacaine 62 hyperuricemia 62 thyrotropin levels 62 nonsevere 62 long acting bronchodilator 62 TNF blocker therapy 62 inotropic agents 62 platelet inhibition 62 antimetabolite 62 myeloproliferative neoplasms 62 headache nasopharyngitis 62 ibandronate

Back to home page